Met dank overgenomen van Europese Commissie (EC), gepubliceerd op vrijdag 11 december 2020. With which companies have you concluded COVID-19 vaccine agreements? The Commission is negotiating intensely to build a diversified portfolio of vaccines at fair prices. Contracts have been concluded with AstraZeneca (400 million doses), Sanofi-GSK (300 million doses), Johnson and Johnson (doses covering 400 million people), BioNTech-Pfizer (300 million doses), CureVac (405 million doses) and Moderna (160 million doses). Member States also have the option to donate vaccines to lower and middle income countries. Which vaccine candidates are currently being reviewed by the European Medicines Agency? The European Medicines Agency (EMA) has received an application for a conditional marketing authorisation for the vaccine developed by BioNTech and Pfizer and will deliver the assessment by 29 December at the latest.